BioSpace News Archive

Drug Development

Novartis AG Drug Gleevec(R) Shows Significant Overall Survival Benefit for Patients With GIST After Three Years of Adjuvant Treatment vs. One Year

June 6, 2011
·
10 min read
Ipsen Announces Discontinuation of the Development of Irosustat in Monotherapy

June 6, 2011
·
1 min read
Drug Development

Sunesis Pharmaceuticals, Inc. Announces Presentation of Adaptive Study Design for Vosaroxin Phase 3 VALOR Trial in AML at American Society of Clinical Oncology 2011 Annual Meeting

June 6, 2011
·
1 min read
Drug Development

PROLOR Biotech Reports Positive Preclinical Results in Weight Loss Study of Its Long-Acting Anti-Obesity Drug Candidate

June 6, 2011
·
5 min read
Pharm Country

Chiasma Inc.'s Octreolin(TM) (Oral Octreotide) Shown to Inhibit Growth Hormone in Healthy Subjects

June 6, 2011
·
6 min read
Drug Development

Acorda Therapeutics New Clinical Data Analysis of AMPYRA(R) (Dalfampridine) Shows Improvement of Patient-Reported Walking Ability Across a Range of Walking Impairment

June 6, 2011
·
1 min read
BioMidwest

Veridex, LLC Release: Late-Breaking American Society of Clinical Oncology Data Demonstrate Circulating Tumor Cells as Potential Biomarker for Metastatic Prostate Cancer Clinical Trials

June 6, 2011
·
4 min read
Drug Development

EntreMed, Inc.'s ENMD-2076 Demonstrates Clinical Activity in Recurrent, Platinum-Resistant Ovarian Cancer Patients

June 6, 2011
·
5 min read
Pharm Country

Quest Diagnostics Inc. to Speak at the Jefferies and Co. 2011 Global Healthcare Conference

June 6, 2011
·
1 min read
Biotech Bay

Onyx Pharmaceuticals, Inc. to Present at the Goldman, Sachs & Co. 32nd Annual Global Healthcare Conference

June 6, 2011
·
1 min read